Allergen-specific immunotherapy provides long-term disease modification for canine atopic dermatitis with welfare benefits beyond symptom control.
Immunotherapy offers the possibility of long-term disease modification for atopic dogs - reducing the underlying immune response rather than simply masking symptoms. For dogs that respond, immunotherapy provides sustained pruritus reduction with minimal side effects, dramatically improving quality of life over years of management. The welfare benefit of effective long-term disease modification exceeds that of ongoing symptomatic treatment.